What You Should Know:
– PrognomiQ, a healthcare company pioneering multi-omics approaches to disease detection, has secured $34M in Series D funding led by Seer, Inc., with participation from a new strategic investor and existing…
Continue Reading
What You Should Know:
– Volpara Health, a global leader in cancer detection software, has been awarded a significant contract with the U.S. Defense Health Agency (DHA) valued at $7.3M over five years.
– The contract…
Continue Reading
The NHS is piloting an iPhone device and app that helps detect throat cancer earlier and give patients the all-clear for the disease faster.
An initial trial on triaged low-risk patients at University Hospitals of…
What You Should Know:
– Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round.
– This investment, co-led by Smart Family…
Continue Reading
Introduction
Artificial intelligence (AI) is transforming breast cancer detection by enhancing early diagnosis and alleviating radiologist workload, essential for improving patient outcomes and screening efficiency. A recent study, conducted by researchers from Norway and Denmark,…
What You Should Know:
– Nebraska Medicine, the clinical partner of the University of Nebraska Medical Center, achieved a nearly 6x increase in lung cancer risk assessment completion through a collaboration with CancerIQ, a best-in-class cancer-focused…
Continue Reading
Detecting Prostate Cancer with Revolutionary AI Tool
The integration of artificial intelligence (AI) in healthcare has revolutionized the way medical professionals diagnose and treat various diseases. A new study published in BJUI Compass confirms the…
What You Should Know:
– A new study presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer offers exciting possibilities for early lung cancer detection.
– Researchers…
Continue Reading
The use of autonomous AI could improve effectiveness and reducing wait times for skin cancer pathways, according to a report commissioned by NHS England.
AI as a medical device (AIaMD) is employed under human supervision…
What You Should Know:
– CancerIQ, a Chicago, IL-based precision health platform focused on empowering healthcare providers to personalize cancer prevention and early detection announced it has secured a growth funding package from Decathlon Capital…
Continue Reading
